Hemcheck Sweden AB (publ) has received a follow-up order from its French distributor, Eurobio Scientific, corresponding to approximately SEK 80,000. The order concerns instruments for diagnostic use.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 SEK | -33.33% |
|
-2.44% | -49.58% |
May. 13 | Bio Vitos Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 14 | Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-49.58% | 5.02M | |
+99.39% | 7.36B | |
-21.23% | 6.62B | |
+7.89% | 5.73B | |
-22.19% | 3.46B | |
+6.24% | 2.5B | |
+35.32% | 2.28B | |
-7.91% | 2.22B | |
-69.64% | 1.88B | |
-18.50% | 1.57B |
- Stock Market
- Equities
- BIOVIT Stock
- News Bio Vitos Pharma AB
- Hemcheck Sweden AB Receives Follow-Up Order from Eurobio Scientific